nodes	percent_of_prediction	percent_of_DWPC	metapath
Memantine—CYP2A6—Prednisolone—ankylosing spondylitis	0.189	0.383	CbGbCtD
Memantine—CYP2A6—Dexamethasone—ankylosing spondylitis	0.112	0.226	CbGbCtD
Memantine—CYP2C19—Prednisone—ankylosing spondylitis	0.074	0.15	CbGbCtD
Memantine—CYP2B6—Dexamethasone—ankylosing spondylitis	0.0727	0.147	CbGbCtD
Memantine—CYP2C19—Dexamethasone—ankylosing spondylitis	0.0462	0.0935	CbGbCtD
Memantine—Infection—Triamcinolone—ankylosing spondylitis	0.000371	0.000733	CcSEcCtD
Memantine—Infection—Methylprednisolone—ankylosing spondylitis	0.00037	0.000731	CcSEcCtD
Memantine—Haematuria—Methotrexate—ankylosing spondylitis	0.000369	0.000728	CcSEcCtD
Memantine—Shock—Triamcinolone—ankylosing spondylitis	0.000367	0.000726	CcSEcCtD
Memantine—Insomnia—Prednisolone—ankylosing spondylitis	0.000367	0.000726	CcSEcCtD
Memantine—Alopecia—Prednisone—ankylosing spondylitis	0.000367	0.000725	CcSEcCtD
Memantine—Shock—Methylprednisolone—ankylosing spondylitis	0.000367	0.000724	CcSEcCtD
Memantine—Hepatobiliary disease—Methotrexate—ankylosing spondylitis	0.000366	0.000722	CcSEcCtD
Memantine—Nervous system disorder—Methylprednisolone—ankylosing spondylitis	0.000365	0.000722	CcSEcCtD
Memantine—Loss of consciousness—Betamethasone—ankylosing spondylitis	0.000365	0.000721	CcSEcCtD
Memantine—Loss of consciousness—Dexamethasone—ankylosing spondylitis	0.000365	0.000721	CcSEcCtD
Memantine—Epistaxis—Methotrexate—ankylosing spondylitis	0.000365	0.00072	CcSEcCtD
Memantine—Paraesthesia—Prednisolone—ankylosing spondylitis	0.000365	0.00072	CcSEcCtD
Memantine—Tachycardia—Triamcinolone—ankylosing spondylitis	0.000364	0.00072	CcSEcCtD
Memantine—Mental disorder—Prednisone—ankylosing spondylitis	0.000364	0.000719	CcSEcCtD
Memantine—Tachycardia—Methylprednisolone—ankylosing spondylitis	0.000364	0.000718	CcSEcCtD
Memantine—Skin disorder—Methylprednisolone—ankylosing spondylitis	0.000362	0.000715	CcSEcCtD
Memantine—Malnutrition—Prednisone—ankylosing spondylitis	0.000362	0.000714	CcSEcCtD
Memantine—Hyperhidrosis—Triamcinolone—ankylosing spondylitis	0.000361	0.000713	CcSEcCtD
Memantine—Agranulocytosis—Methotrexate—ankylosing spondylitis	0.000361	0.000713	CcSEcCtD
Memantine—Hyperhidrosis—Methylprednisolone—ankylosing spondylitis	0.00036	0.000712	CcSEcCtD
Memantine—Convulsion—Dexamethasone—ankylosing spondylitis	0.00036	0.000711	CcSEcCtD
Memantine—Convulsion—Betamethasone—ankylosing spondylitis	0.00036	0.000711	CcSEcCtD
Memantine—Hypertension—Dexamethasone—ankylosing spondylitis	0.000358	0.000708	CcSEcCtD
Memantine—Hypertension—Betamethasone—ankylosing spondylitis	0.000358	0.000708	CcSEcCtD
Memantine—Myalgia—Dexamethasone—ankylosing spondylitis	0.000353	0.000698	CcSEcCtD
Memantine—Myalgia—Betamethasone—ankylosing spondylitis	0.000353	0.000698	CcSEcCtD
Memantine—Anxiety—Dexamethasone—ankylosing spondylitis	0.000352	0.000696	CcSEcCtD
Memantine—Anxiety—Betamethasone—ankylosing spondylitis	0.000352	0.000696	CcSEcCtD
Memantine—Discomfort—Dexamethasone—ankylosing spondylitis	0.000349	0.00069	CcSEcCtD
Memantine—Discomfort—Betamethasone—ankylosing spondylitis	0.000349	0.00069	CcSEcCtD
Memantine—Haemoglobin—Methotrexate—ankylosing spondylitis	0.000349	0.000689	CcSEcCtD
Memantine—Hypotension—Methylprednisolone—ankylosing spondylitis	0.000348	0.000688	CcSEcCtD
Memantine—Pain—Prednisolone—ankylosing spondylitis	0.000347	0.000686	CcSEcCtD
Memantine—Haemorrhage—Methotrexate—ankylosing spondylitis	0.000347	0.000686	CcSEcCtD
Memantine—Hepatitis—Methotrexate—ankylosing spondylitis	0.000347	0.000686	CcSEcCtD
Memantine—Pharyngitis—Methotrexate—ankylosing spondylitis	0.000344	0.000681	CcSEcCtD
Memantine—Urinary tract disorder—Methotrexate—ankylosing spondylitis	0.000343	0.000677	CcSEcCtD
Memantine—Vision blurred—Prednisone—ankylosing spondylitis	0.000341	0.000673	CcSEcCtD
Memantine—Urethral disorder—Methotrexate—ankylosing spondylitis	0.00034	0.000672	CcSEcCtD
Memantine—Musculoskeletal discomfort—Triamcinolone—ankylosing spondylitis	0.00034	0.000672	CcSEcCtD
Memantine—Musculoskeletal discomfort—Methylprednisolone—ankylosing spondylitis	0.000339	0.000671	CcSEcCtD
Memantine—Oedema—Betamethasone—ankylosing spondylitis	0.000339	0.000669	CcSEcCtD
Memantine—Oedema—Dexamethasone—ankylosing spondylitis	0.000339	0.000669	CcSEcCtD
Memantine—Insomnia—Triamcinolone—ankylosing spondylitis	0.000338	0.000667	CcSEcCtD
Memantine—Insomnia—Methylprednisolone—ankylosing spondylitis	0.000337	0.000666	CcSEcCtD
Memantine—Infection—Betamethasone—ankylosing spondylitis	0.000337	0.000665	CcSEcCtD
Memantine—Infection—Dexamethasone—ankylosing spondylitis	0.000337	0.000665	CcSEcCtD
Memantine—Ill-defined disorder—Prednisone—ankylosing spondylitis	0.000335	0.000663	CcSEcCtD
Memantine—Paraesthesia—Triamcinolone—ankylosing spondylitis	0.000335	0.000662	CcSEcCtD
Memantine—Feeling abnormal—Prednisolone—ankylosing spondylitis	0.000335	0.000661	CcSEcCtD
Memantine—Paraesthesia—Methylprednisolone—ankylosing spondylitis	0.000335	0.000661	CcSEcCtD
Memantine—Visual impairment—Methotrexate—ankylosing spondylitis	0.000334	0.000661	CcSEcCtD
Memantine—Anaemia—Prednisone—ankylosing spondylitis	0.000334	0.00066	CcSEcCtD
Memantine—Shock—Betamethasone—ankylosing spondylitis	0.000333	0.000659	CcSEcCtD
Memantine—Shock—Dexamethasone—ankylosing spondylitis	0.000333	0.000659	CcSEcCtD
Memantine—Dyspnoea—Triamcinolone—ankylosing spondylitis	0.000333	0.000658	CcSEcCtD
Memantine—Nervous system disorder—Dexamethasone—ankylosing spondylitis	0.000332	0.000656	CcSEcCtD
Memantine—Nervous system disorder—Betamethasone—ankylosing spondylitis	0.000332	0.000656	CcSEcCtD
Memantine—Agitation—Prednisone—ankylosing spondylitis	0.000332	0.000656	CcSEcCtD
Memantine—Thrombocytopenia—Dexamethasone—ankylosing spondylitis	0.000332	0.000655	CcSEcCtD
Memantine—Thrombocytopenia—Betamethasone—ankylosing spondylitis	0.000332	0.000655	CcSEcCtD
Memantine—Tachycardia—Betamethasone—ankylosing spondylitis	0.000331	0.000653	CcSEcCtD
Memantine—Tachycardia—Dexamethasone—ankylosing spondylitis	0.000331	0.000653	CcSEcCtD
Memantine—Dyspepsia—Triamcinolone—ankylosing spondylitis	0.000329	0.000649	CcSEcCtD
Memantine—Erythema multiforme—Methotrexate—ankylosing spondylitis	0.000328	0.000648	CcSEcCtD
Memantine—Dyspepsia—Methylprednisolone—ankylosing spondylitis	0.000328	0.000648	CcSEcCtD
Memantine—Hyperhidrosis—Dexamethasone—ankylosing spondylitis	0.000328	0.000647	CcSEcCtD
Memantine—Hyperhidrosis—Betamethasone—ankylosing spondylitis	0.000328	0.000647	CcSEcCtD
Memantine—Malaise—Prednisone—ankylosing spondylitis	0.000326	0.000644	CcSEcCtD
Memantine—Vertigo—Prednisone—ankylosing spondylitis	0.000325	0.000642	CcSEcCtD
Memantine—Eye disorder—Methotrexate—ankylosing spondylitis	0.000324	0.000641	CcSEcCtD
Memantine—Syncope—Prednisone—ankylosing spondylitis	0.000324	0.000641	CcSEcCtD
Memantine—Tinnitus—Methotrexate—ankylosing spondylitis	0.000324	0.000639	CcSEcCtD
Memantine—Anorexia—Dexamethasone—ankylosing spondylitis	0.000323	0.000638	CcSEcCtD
Memantine—Anorexia—Betamethasone—ankylosing spondylitis	0.000323	0.000638	CcSEcCtD
Memantine—Urticaria—Prednisolone—ankylosing spondylitis	0.000323	0.000637	CcSEcCtD
Memantine—Cardiac disorder—Methotrexate—ankylosing spondylitis	0.000322	0.000636	CcSEcCtD
Memantine—Fatigue—Triamcinolone—ankylosing spondylitis	0.000322	0.000636	CcSEcCtD
Memantine—Fatigue—Methylprednisolone—ankylosing spondylitis	0.000321	0.000635	CcSEcCtD
Memantine—Pain—Triamcinolone—ankylosing spondylitis	0.000319	0.000631	CcSEcCtD
Memantine—Loss of consciousness—Prednisone—ankylosing spondylitis	0.000318	0.000628	CcSEcCtD
Memantine—Hypotension—Betamethasone—ankylosing spondylitis	0.000317	0.000625	CcSEcCtD
Memantine—Hypotension—Dexamethasone—ankylosing spondylitis	0.000317	0.000625	CcSEcCtD
Memantine—Angiopathy—Methotrexate—ankylosing spondylitis	0.000315	0.000622	CcSEcCtD
Memantine—Immune system disorder—Methotrexate—ankylosing spondylitis	0.000314	0.000619	CcSEcCtD
Memantine—Convulsion—Prednisone—ankylosing spondylitis	0.000313	0.000619	CcSEcCtD
Memantine—Mediastinal disorder—Methotrexate—ankylosing spondylitis	0.000313	0.000618	CcSEcCtD
Memantine—Hypertension—Prednisone—ankylosing spondylitis	0.000312	0.000617	CcSEcCtD
Memantine—Chills—Methotrexate—ankylosing spondylitis	0.000311	0.000615	CcSEcCtD
Memantine—Musculoskeletal discomfort—Dexamethasone—ankylosing spondylitis	0.000309	0.00061	CcSEcCtD
Memantine—Musculoskeletal discomfort—Betamethasone—ankylosing spondylitis	0.000309	0.00061	CcSEcCtD
Memantine—Arthralgia—Prednisone—ankylosing spondylitis	0.000308	0.000608	CcSEcCtD
Memantine—Myalgia—Prednisone—ankylosing spondylitis	0.000308	0.000608	CcSEcCtD
Memantine—Feeling abnormal—Triamcinolone—ankylosing spondylitis	0.000308	0.000608	CcSEcCtD
Memantine—Feeling abnormal—Methylprednisolone—ankylosing spondylitis	0.000307	0.000607	CcSEcCtD
Memantine—Anxiety—Prednisone—ankylosing spondylitis	0.000307	0.000606	CcSEcCtD
Memantine—Alopecia—Methotrexate—ankylosing spondylitis	0.000307	0.000606	CcSEcCtD
Memantine—Insomnia—Dexamethasone—ankylosing spondylitis	0.000306	0.000605	CcSEcCtD
Memantine—Insomnia—Betamethasone—ankylosing spondylitis	0.000306	0.000605	CcSEcCtD
Memantine—Gastrointestinal pain—Methylprednisolone—ankylosing spondylitis	0.000305	0.000602	CcSEcCtD
Memantine—Paraesthesia—Dexamethasone—ankylosing spondylitis	0.000304	0.000601	CcSEcCtD
Memantine—Paraesthesia—Betamethasone—ankylosing spondylitis	0.000304	0.000601	CcSEcCtD
Memantine—Discomfort—Prednisone—ankylosing spondylitis	0.000304	0.000601	CcSEcCtD
Memantine—Mental disorder—Methotrexate—ankylosing spondylitis	0.000304	0.000601	CcSEcCtD
Memantine—Malnutrition—Methotrexate—ankylosing spondylitis	0.000302	0.000597	CcSEcCtD
Memantine—Hypersensitivity—Prednisolone—ankylosing spondylitis	0.000299	0.000591	CcSEcCtD
Memantine—Dyspepsia—Betamethasone—ankylosing spondylitis	0.000298	0.000589	CcSEcCtD
Memantine—Dyspepsia—Dexamethasone—ankylosing spondylitis	0.000298	0.000589	CcSEcCtD
Memantine—Urticaria—Triamcinolone—ankylosing spondylitis	0.000297	0.000586	CcSEcCtD
Memantine—Urticaria—Methylprednisolone—ankylosing spondylitis	0.000296	0.000585	CcSEcCtD
Memantine—Dysgeusia—Methotrexate—ankylosing spondylitis	0.000296	0.000585	CcSEcCtD
Memantine—Body temperature increased—Triamcinolone—ankylosing spondylitis	0.000295	0.000583	CcSEcCtD
Memantine—Oedema—Prednisone—ankylosing spondylitis	0.000295	0.000583	CcSEcCtD
Memantine—Abdominal pain—Methylprednisolone—ankylosing spondylitis	0.000295	0.000582	CcSEcCtD
Memantine—Decreased appetite—Betamethasone—ankylosing spondylitis	0.000295	0.000582	CcSEcCtD
Memantine—Decreased appetite—Dexamethasone—ankylosing spondylitis	0.000295	0.000582	CcSEcCtD
Memantine—Infection—Prednisone—ankylosing spondylitis	0.000293	0.000579	CcSEcCtD
Memantine—Gastrointestinal disorder—Betamethasone—ankylosing spondylitis	0.000293	0.000578	CcSEcCtD
Memantine—Gastrointestinal disorder—Dexamethasone—ankylosing spondylitis	0.000293	0.000578	CcSEcCtD
Memantine—Back pain—Methotrexate—ankylosing spondylitis	0.000292	0.000577	CcSEcCtD
Memantine—Fatigue—Dexamethasone—ankylosing spondylitis	0.000292	0.000577	CcSEcCtD
Memantine—Fatigue—Betamethasone—ankylosing spondylitis	0.000292	0.000577	CcSEcCtD
Memantine—Shock—Prednisone—ankylosing spondylitis	0.00029	0.000574	CcSEcCtD
Memantine—Pain—Dexamethasone—ankylosing spondylitis	0.00029	0.000572	CcSEcCtD
Memantine—Pain—Betamethasone—ankylosing spondylitis	0.00029	0.000572	CcSEcCtD
Memantine—Nervous system disorder—Prednisone—ankylosing spondylitis	0.000289	0.000572	CcSEcCtD
Memantine—Tachycardia—Prednisone—ankylosing spondylitis	0.000288	0.000569	CcSEcCtD
Memantine—Skin disorder—Prednisone—ankylosing spondylitis	0.000287	0.000566	CcSEcCtD
Memantine—Hyperhidrosis—Prednisone—ankylosing spondylitis	0.000285	0.000564	CcSEcCtD
Memantine—Vision blurred—Methotrexate—ankylosing spondylitis	0.000285	0.000563	CcSEcCtD
Memantine—Anorexia—Prednisone—ankylosing spondylitis	0.000281	0.000556	CcSEcCtD
Memantine—Ill-defined disorder—Methotrexate—ankylosing spondylitis	0.00028	0.000554	CcSEcCtD
Memantine—Anaemia—Methotrexate—ankylosing spondylitis	0.000279	0.000552	CcSEcCtD
Memantine—Feeling abnormal—Dexamethasone—ankylosing spondylitis	0.000279	0.000552	CcSEcCtD
Memantine—Feeling abnormal—Betamethasone—ankylosing spondylitis	0.000279	0.000552	CcSEcCtD
Memantine—Gastrointestinal pain—Betamethasone—ankylosing spondylitis	0.000277	0.000547	CcSEcCtD
Memantine—Gastrointestinal pain—Dexamethasone—ankylosing spondylitis	0.000277	0.000547	CcSEcCtD
Memantine—Hypersensitivity—Triamcinolone—ankylosing spondylitis	0.000275	0.000544	CcSEcCtD
Memantine—Hypersensitivity—Methylprednisolone—ankylosing spondylitis	0.000275	0.000542	CcSEcCtD
Memantine—Malaise—Methotrexate—ankylosing spondylitis	0.000272	0.000538	CcSEcCtD
Memantine—Vertigo—Methotrexate—ankylosing spondylitis	0.000271	0.000536	CcSEcCtD
Memantine—Leukopenia—Methotrexate—ankylosing spondylitis	0.00027	0.000534	CcSEcCtD
Memantine—Urticaria—Betamethasone—ankylosing spondylitis	0.000269	0.000532	CcSEcCtD
Memantine—Urticaria—Dexamethasone—ankylosing spondylitis	0.000269	0.000532	CcSEcCtD
Memantine—Musculoskeletal discomfort—Prednisone—ankylosing spondylitis	0.000269	0.000531	CcSEcCtD
Memantine—Dizziness—Prednisolone—ankylosing spondylitis	0.000269	0.00053	CcSEcCtD
Memantine—Asthenia—Triamcinolone—ankylosing spondylitis	0.000268	0.000529	CcSEcCtD
Memantine—Abdominal pain—Dexamethasone—ankylosing spondylitis	0.000268	0.000529	CcSEcCtD
Memantine—Body temperature increased—Dexamethasone—ankylosing spondylitis	0.000268	0.000529	CcSEcCtD
Memantine—Body temperature increased—Betamethasone—ankylosing spondylitis	0.000268	0.000529	CcSEcCtD
Memantine—Abdominal pain—Betamethasone—ankylosing spondylitis	0.000268	0.000529	CcSEcCtD
Memantine—Asthenia—Methylprednisolone—ankylosing spondylitis	0.000267	0.000528	CcSEcCtD
Memantine—Insomnia—Prednisone—ankylosing spondylitis	0.000267	0.000527	CcSEcCtD
Memantine—Paraesthesia—Prednisone—ankylosing spondylitis	0.000265	0.000523	CcSEcCtD
Memantine—Pruritus—Triamcinolone—ankylosing spondylitis	0.000264	0.000522	CcSEcCtD
Memantine—Cough—Methotrexate—ankylosing spondylitis	0.000264	0.000521	CcSEcCtD
Memantine—Pruritus—Methylprednisolone—ankylosing spondylitis	0.000264	0.000521	CcSEcCtD
Memantine—Convulsion—Methotrexate—ankylosing spondylitis	0.000262	0.000517	CcSEcCtD
Memantine—Dyspepsia—Prednisone—ankylosing spondylitis	0.00026	0.000513	CcSEcCtD
Memantine—Arthralgia—Methotrexate—ankylosing spondylitis	0.000257	0.000508	CcSEcCtD
Memantine—Myalgia—Methotrexate—ankylosing spondylitis	0.000257	0.000508	CcSEcCtD
Memantine—Chest pain—Methotrexate—ankylosing spondylitis	0.000257	0.000508	CcSEcCtD
Memantine—Decreased appetite—Prednisone—ankylosing spondylitis	0.000257	0.000507	CcSEcCtD
Memantine—Rash—Prednisolone—ankylosing spondylitis	0.000256	0.000506	CcSEcCtD
Memantine—Dermatitis—Prednisolone—ankylosing spondylitis	0.000256	0.000505	CcSEcCtD
Memantine—Diarrhoea—Methylprednisolone—ankylosing spondylitis	0.000255	0.000504	CcSEcCtD
Memantine—Fatigue—Prednisone—ankylosing spondylitis	0.000254	0.000503	CcSEcCtD
Memantine—Headache—Prednisolone—ankylosing spondylitis	0.000254	0.000503	CcSEcCtD
Memantine—Discomfort—Methotrexate—ankylosing spondylitis	0.000254	0.000502	CcSEcCtD
Memantine—Constipation—Prednisone—ankylosing spondylitis	0.000252	0.000498	CcSEcCtD
Memantine—Confusional state—Methotrexate—ankylosing spondylitis	0.000249	0.000491	CcSEcCtD
Memantine—Dizziness—Triamcinolone—ankylosing spondylitis	0.000247	0.000488	CcSEcCtD
Memantine—Dizziness—Methylprednisolone—ankylosing spondylitis	0.000246	0.000487	CcSEcCtD
Memantine—Infection—Methotrexate—ankylosing spondylitis	0.000245	0.000484	CcSEcCtD
Memantine—Feeling abnormal—Prednisone—ankylosing spondylitis	0.000243	0.00048	CcSEcCtD
Memantine—Asthenia—Dexamethasone—ankylosing spondylitis	0.000243	0.00048	CcSEcCtD
Memantine—Asthenia—Betamethasone—ankylosing spondylitis	0.000243	0.00048	CcSEcCtD
Memantine—Nervous system disorder—Methotrexate—ankylosing spondylitis	0.000242	0.000478	CcSEcCtD
Memantine—Thrombocytopenia—Methotrexate—ankylosing spondylitis	0.000241	0.000477	CcSEcCtD
Memantine—Gastrointestinal pain—Prednisone—ankylosing spondylitis	0.000241	0.000477	CcSEcCtD
Memantine—Nausea—Prednisolone—ankylosing spondylitis	0.000241	0.000476	CcSEcCtD
Memantine—Pruritus—Dexamethasone—ankylosing spondylitis	0.00024	0.000474	CcSEcCtD
Memantine—Pruritus—Betamethasone—ankylosing spondylitis	0.00024	0.000474	CcSEcCtD
Memantine—Skin disorder—Methotrexate—ankylosing spondylitis	0.00024	0.000473	CcSEcCtD
Memantine—Hyperhidrosis—Methotrexate—ankylosing spondylitis	0.000238	0.000471	CcSEcCtD
Memantine—Vomiting—Triamcinolone—ankylosing spondylitis	0.000237	0.000469	CcSEcCtD
Memantine—Vomiting—Methylprednisolone—ankylosing spondylitis	0.000237	0.000468	CcSEcCtD
Memantine—Rash—Triamcinolone—ankylosing spondylitis	0.000235	0.000465	CcSEcCtD
Memantine—Dermatitis—Triamcinolone—ankylosing spondylitis	0.000235	0.000465	CcSEcCtD
Memantine—Anorexia—Methotrexate—ankylosing spondylitis	0.000235	0.000464	CcSEcCtD
Memantine—Rash—Methylprednisolone—ankylosing spondylitis	0.000235	0.000464	CcSEcCtD
Memantine—Dermatitis—Methylprednisolone—ankylosing spondylitis	0.000235	0.000464	CcSEcCtD
Memantine—Urticaria—Prednisone—ankylosing spondylitis	0.000234	0.000463	CcSEcCtD
Memantine—Headache—Triamcinolone—ankylosing spondylitis	0.000234	0.000462	CcSEcCtD
Memantine—Headache—Methylprednisolone—ankylosing spondylitis	0.000233	0.000461	CcSEcCtD
Memantine—Abdominal pain—Prednisone—ankylosing spondylitis	0.000233	0.000461	CcSEcCtD
Memantine—Body temperature increased—Prednisone—ankylosing spondylitis	0.000233	0.000461	CcSEcCtD
Memantine—Diarrhoea—Dexamethasone—ankylosing spondylitis	0.000232	0.000458	CcSEcCtD
Memantine—Diarrhoea—Betamethasone—ankylosing spondylitis	0.000232	0.000458	CcSEcCtD
Memantine—Hypotension—Methotrexate—ankylosing spondylitis	0.00023	0.000455	CcSEcCtD
Memantine—Musculoskeletal discomfort—Methotrexate—ankylosing spondylitis	0.000225	0.000444	CcSEcCtD
Memantine—Dizziness—Betamethasone—ankylosing spondylitis	0.000224	0.000443	CcSEcCtD
Memantine—Dizziness—Dexamethasone—ankylosing spondylitis	0.000224	0.000443	CcSEcCtD
Memantine—Insomnia—Methotrexate—ankylosing spondylitis	0.000223	0.000441	CcSEcCtD
Memantine—Nausea—Triamcinolone—ankylosing spondylitis	0.000222	0.000438	CcSEcCtD
Memantine—Paraesthesia—Methotrexate—ankylosing spondylitis	0.000221	0.000437	CcSEcCtD
Memantine—Nausea—Methylprednisolone—ankylosing spondylitis	0.000221	0.000437	CcSEcCtD
Memantine—Dyspnoea—Methotrexate—ankylosing spondylitis	0.00022	0.000434	CcSEcCtD
Memantine—Somnolence—Methotrexate—ankylosing spondylitis	0.000219	0.000433	CcSEcCtD
Memantine—Hypersensitivity—Prednisone—ankylosing spondylitis	0.000217	0.000429	CcSEcCtD
Memantine—Dyspepsia—Methotrexate—ankylosing spondylitis	0.000217	0.000429	CcSEcCtD
Memantine—Vomiting—Dexamethasone—ankylosing spondylitis	0.000215	0.000426	CcSEcCtD
Memantine—Vomiting—Betamethasone—ankylosing spondylitis	0.000215	0.000426	CcSEcCtD
Memantine—Decreased appetite—Methotrexate—ankylosing spondylitis	0.000214	0.000423	CcSEcCtD
Memantine—Rash—Betamethasone—ankylosing spondylitis	0.000214	0.000422	CcSEcCtD
Memantine—Rash—Dexamethasone—ankylosing spondylitis	0.000214	0.000422	CcSEcCtD
Memantine—Dermatitis—Dexamethasone—ankylosing spondylitis	0.000213	0.000422	CcSEcCtD
Memantine—Dermatitis—Betamethasone—ankylosing spondylitis	0.000213	0.000422	CcSEcCtD
Memantine—Gastrointestinal disorder—Methotrexate—ankylosing spondylitis	0.000213	0.000421	CcSEcCtD
Memantine—Fatigue—Methotrexate—ankylosing spondylitis	0.000213	0.00042	CcSEcCtD
Memantine—Headache—Dexamethasone—ankylosing spondylitis	0.000212	0.000419	CcSEcCtD
Memantine—Headache—Betamethasone—ankylosing spondylitis	0.000212	0.000419	CcSEcCtD
Memantine—Asthenia—Prednisone—ankylosing spondylitis	0.000212	0.000418	CcSEcCtD
Memantine—Pain—Methotrexate—ankylosing spondylitis	0.000211	0.000417	CcSEcCtD
Memantine—Pruritus—Prednisone—ankylosing spondylitis	0.000209	0.000412	CcSEcCtD
Memantine—Feeling abnormal—Methotrexate—ankylosing spondylitis	0.000203	0.000401	CcSEcCtD
Memantine—Diarrhoea—Prednisone—ankylosing spondylitis	0.000202	0.000399	CcSEcCtD
Memantine—Gastrointestinal pain—Methotrexate—ankylosing spondylitis	0.000202	0.000398	CcSEcCtD
Memantine—Nausea—Betamethasone—ankylosing spondylitis	0.000201	0.000398	CcSEcCtD
Memantine—Nausea—Dexamethasone—ankylosing spondylitis	0.000201	0.000398	CcSEcCtD
Memantine—Urticaria—Methotrexate—ankylosing spondylitis	0.000196	0.000387	CcSEcCtD
Memantine—Dizziness—Prednisone—ankylosing spondylitis	0.000195	0.000385	CcSEcCtD
Memantine—Abdominal pain—Methotrexate—ankylosing spondylitis	0.000195	0.000385	CcSEcCtD
Memantine—Body temperature increased—Methotrexate—ankylosing spondylitis	0.000195	0.000385	CcSEcCtD
Memantine—Vomiting—Prednisone—ankylosing spondylitis	0.000188	0.000371	CcSEcCtD
Memantine—Rash—Prednisone—ankylosing spondylitis	0.000186	0.000368	CcSEcCtD
Memantine—Dermatitis—Prednisone—ankylosing spondylitis	0.000186	0.000367	CcSEcCtD
Memantine—Headache—Prednisone—ankylosing spondylitis	0.000185	0.000365	CcSEcCtD
Memantine—Hypersensitivity—Methotrexate—ankylosing spondylitis	0.000182	0.000359	CcSEcCtD
Memantine—Asthenia—Methotrexate—ankylosing spondylitis	0.000177	0.00035	CcSEcCtD
Memantine—Nausea—Prednisone—ankylosing spondylitis	0.000175	0.000346	CcSEcCtD
Memantine—Pruritus—Methotrexate—ankylosing spondylitis	0.000174	0.000345	CcSEcCtD
Memantine—Diarrhoea—Methotrexate—ankylosing spondylitis	0.000169	0.000333	CcSEcCtD
Memantine—Dizziness—Methotrexate—ankylosing spondylitis	0.000163	0.000322	CcSEcCtD
Memantine—Vomiting—Methotrexate—ankylosing spondylitis	0.000157	0.00031	CcSEcCtD
Memantine—Rash—Methotrexate—ankylosing spondylitis	0.000155	0.000307	CcSEcCtD
Memantine—Dermatitis—Methotrexate—ankylosing spondylitis	0.000155	0.000307	CcSEcCtD
Memantine—Headache—Methotrexate—ankylosing spondylitis	0.000154	0.000305	CcSEcCtD
Memantine—Nausea—Methotrexate—ankylosing spondylitis	0.000146	0.000289	CcSEcCtD
